Sponsor or institution

Clinical trials and research at Chongqing Claruvis Pharmaceutical Co., Ltd.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Recombinant botulinum toxin (YY001) injections for adult upper limb spasticity.

  This trial will test repeated injections of recombinant botulinum toxin type A (YY001) to reduce muscle stiffness and improve function in adults with post-stroke upper limb spasticity.

  Recruiting at 16 sites Phase 3 Chongqing Claruvis Pharmaceutical Co., Ltd. · Beijing and 15 other locations · NCT07478822

• Using a new botulinum toxin injection to treat upper limb spasticity in adults

  This study is testing a new injection for adults with upper limb spasticity to see if it works better than current treatments like BOTOX® and helps improve their movement.

  Recruiting at 24 sites Phase 2/3 Chongqing Claruvis Pharmaceutical Co., Ltd. · Hefei, Anhui and 23 other locations · NCT06783114

Quick answers

How many clinical trials run by Chongqing Claruvis Pharmaceutical Co., Ltd. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →